Kara E. Geisel

Array ( [id] => 15975439 [patent_doc_number] => 10668020 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-06-02 [patent_title] => Pullulan based vinpocetine tablets, lyoplant-tabs, as a buccal solid dosage form [patent_app_type] => utility [patent_app_number] => 16/690662 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 10439 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16786029 [patent_doc_number] => 10988441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Alpha-cinnamide compounds and compositions as HDAC8 inhibitors [patent_app_type] => utility [patent_app_number] => 16/689252 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15927615 [patent_doc_number] => 20200155441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => PROCESS FOR MANUFACTURING OMNIPHOBIC COSMETIC PIGMENTS [patent_app_type] => utility [patent_app_number] => 16/684802 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17250049 [patent_doc_number] => 11185517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-30 [patent_title] => Pharmaceutical composition for treatment or remission of chronic myelogenous leukemia [patent_app_type] => utility [patent_app_number] => 16/684091 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3588 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17292110 [patent_doc_number] => 20210387949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => NEW SELECTIVE MODULATORS OF INSECT NICOTINIC ACETYLCHOLINE RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/291791 [patent_app_country] => US [patent_app_date] => 2019-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17272887 [patent_doc_number] => 20210379085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => HALOGENATED SALICYLANILIDES FOR TREATING THE SYMPTOMS OF DERMATITIS [patent_app_type] => utility [patent_app_number] => 17/290353 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15524905 [patent_doc_number] => 20200054758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => OLIGOLACTIC ACID CONJUGATES AND MICELLES WITH ENHANCED ANTICANCER EFFICACY [patent_app_type] => utility [patent_app_number] => 16/664680 [patent_app_country] => US [patent_app_date] => 2019-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13475 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16664680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15726603 [patent_doc_number] => 10611722 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-04-07 [patent_title] => Cationic lipids and transfection methods [patent_app_type] => utility [patent_app_number] => 16/660317 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7553 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15483045 [patent_doc_number] => 10556855 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-02-11 [patent_title] => Cationic lipids and transfection methods [patent_app_type] => utility [patent_app_number] => 16/660299 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7552 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16589248 [patent_doc_number] => 10898490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-26 [patent_title] => Method for treating cancer [patent_app_type] => utility [patent_app_number] => 16/660185 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14550 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16197306 [patent_doc_number] => 10722442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Skin brightening composition comprising novel ginsenoside [patent_app_type] => utility [patent_app_number] => 16/656082 [patent_app_country] => US [patent_app_date] => 2019-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7351 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15768579 [patent_doc_number] => 20200115307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => Series of Compounds for Treatment of Skin Diseases and Other Conditions [patent_app_type] => utility [patent_app_number] => 16/600536 [patent_app_country] => US [patent_app_date] => 2019-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14167 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15435311 [patent_doc_number] => 20200031839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE [patent_app_type] => utility [patent_app_number] => 16/593523 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1438 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15432633 [patent_doc_number] => 20200030499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => CHLORHEXIDINE GLUCONATE COMPOSITIONS RESIN SYSTEMS AND ARTICLES [patent_app_type] => utility [patent_app_number] => 16/590594 [patent_app_country] => US [patent_app_date] => 2019-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16590594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15866003 [patent_doc_number] => 20200140405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => COMPOSITIONS COMPRISING AN UROLITHIN COMPOUND [patent_app_type] => utility [patent_app_number] => 16/589890 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19241980 [patent_doc_number] => 12012399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-18 [patent_title] => Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives [patent_app_type] => utility [patent_app_number] => 17/282109 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26392 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 383 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15432231 [patent_doc_number] => 20200030298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists [patent_app_type] => utility [patent_app_number] => 16/578294 [patent_app_country] => US [patent_app_date] => 2019-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16578294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15320787 [patent_doc_number] => 20200000723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => BIODEGRADABLE COMPOUND, LIPID PARTICLES, COMPOSITION AND KIT COMPRISING LIPID PARTICLES [patent_app_type] => utility [patent_app_number] => 16/567895 [patent_app_country] => US [patent_app_date] => 2019-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6343 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16567895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15422349 [patent_doc_number] => 10544087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Process for the reductive amination of halogen-containing substrates [patent_app_type] => utility [patent_app_number] => 16/565595 [patent_app_country] => US [patent_app_date] => 2019-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16219 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16912929 [patent_doc_number] => 20210186021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => DIAMINOTRIAZINE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/270884 [patent_app_country] => US [patent_app_date] => 2019-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 753 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270884 [rel_patent_id] =>[rel_patent_doc_number] =>)